Skip to main content
Clinical Trials/CTRI/2023/04/052065
CTRI/2023/04/052065
Not Yet Recruiting
Phase 2

A Randomized Clinical Study To Evaluate The Efficacy Of Madhumehadaman Churna and Phaltrikadi Kwatha In The Management Of Madhumeha W.S.R. Type 2 Diabetes Mellitus

Ayurvedic and Unani Tibbia College Hospital.0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ayurvedic and Unani Tibbia College Hospital.
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurvedic and Unani Tibbia College Hospital.

Eligibility Criteria

Inclusion Criteria

  • 1\-Patients of either sex aged between 20\-65 years
  • 2\-If yes in any two of four :
  • Blood sugar fasting\- 125 \- 150 mg/dl.
  • PP\- 199\-250 mg/dl.
  • Glycosylated Haemoglobin (HbA1c) 6\.4% \- 7\.5%
  • Subjects having classical symptoms of diabetes with random glucose levels
  • \>\=200mg/dl (\<\=250mg/dl)
  • 3\-Subjects who are able to come for follow up on fixed visits and are well aware about
  • the treatment plan.(only type 2 DM patients)
  • 4\-Subjects willing to participate and able to provide written informed consent.

Exclusion Criteria

  • 1\-Subject on any other AYUSH medication for glucose control.
  • 2\- Patients with type 1 Diabetes Mellitus.
  • 3\-Subjects suffering from the complications of Diabetes mellitus viz., diabetic
  • neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent
  • 4\-Uncontrolled Hypertensive subjects (BP with or without medication \>140/90 mmHg
  • after 5 mins of rest).
  • 5\-Subjects with any unstable Heart disease or known cases of MI, unstable angina or
  • 6\-Subjects with current or past diagnosis of malignancy (any malignancy diagnosis in
  • last five years).
  • 7\-Subjects who have a recent history or who are currently known to abuse of alcohol

Outcomes

Primary Outcomes

Not specified

Similar Trials